http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0723466-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9531cfb72fc3242e30398889c2bd2d2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0275 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-00 |
| filingDate | 1994-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0acf2753a819efbfba6528babeed65 |
| publicationDate | 1996-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0723466-A1 |
| titleOfInvention | Nitric oxide treatment |
| abstract | There are a number of lung diseases and conditions in which the lung's bronchioles and alveoli constrict to restrict the flow of air therethrough. There are additionally a number of lung conditions in which the lung's pulmonary arteries also constrict. A well-known and effective dilating agent for treating both these lung problems is nitric oxide. The obvious way to deliver nitric oxide to the desired lung sites is by inhalation. The problem, however, is that the concentration of nitric oxide thus delivered must be high enough to have the required therapeutic effect and yet low enough to minimize its rapid conversion to the harmful nitrogen dioxide. The invention proposes both a method of and apparatus for treatment in which, using means (13, 16) for supplying nitric oxide from a source (15) thereof to the patient for inhalation thereby, the supply means incorporating regulator means (16) to control the egress of nitric oxide from the source, together with means (17, 18) to monitor the patient's respiration, and to cause the regulator means to permit the egress of a very short pulse (21) of nitric oxide of a known, predetermined volume at the start of an inhalation, the nitric oxide is administered to the patient intermittently and in very short pulses of known, predetermined duration either at the beginning or towards the end of each inhalation, as appropriate. |
| priorityDate | 1993-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.